Is Latent Autoimmune Diabetes in Adults Distinct From Type 1 Diabetes or Just Type 1 Diabetes at an Older Age?
- 1 December 2005
- journal article
- review article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (suppl_2) , S62-S67
- https://doi.org/10.2337/diabetes.54.suppl_2.s62
Abstract
Diabetes is classified clinically into two types: type 1 and type 2 diabetes. Type 1 diabetes is an autoimmune diabetes, whereas, in contrast, type 2 diabetes is nonautoimmune. However, there is a group of phenotypic adult type 2 diabetic patients (∼10%) who have islet autoantibodies similar to type 1 diabetes. These patients are said to have latent autoimmune diabetes in adults (LADA) or type 1.5 diabetes. T-cells reacting with islet proteins have been demonstrated in type 1 and type 1.5 diabetic patients. In contrast, classic autoantibody-negative type 2 diabetic patients are also negative for T-cell responses to islet proteins. Therefore, we questioned whether type 1 and type 1.5 diabetes are similar or different autoimmune diseases. We have investigated the immunological and metabolic differences between type 1, type 1.5, and classic type 2 diabetic patients. We have identified autoantibody differences, differences in islet proteins recognized by T-cells, and differences in insulin resistance. We have also identified a small group of patients who have T-cells responsive to islet proteins but who are autoantibody negative. These patients appear to be similar to type 1.5 patients in having decreased stimulated C-peptide values. These immunological differences between type 1 and type 1.5 diabetes suggest at least partially distinct disease processes.Keywords
This publication has 32 references indexed in Scilit:
- Variable Number of Tandem Repeats of the Insulin Gene Determines Susceptibility to Latent Autoimmune Diabetes in AdultsMolecular Diagnosis, 2004
- Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes MellitusNew England Journal of Medicine, 2002
- The Importance of -Cell Failure in the Development and Progression of Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2001
- Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2000
- Number of Autoantibodies (Against Insulin, GAD or ICA512/IA2) Rather than Particular Autoantibody Specificities Determines Risk of Type I DiabetesJournal of Autoimmunity, 1996
- Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic functionDiabetes, 1993
- A Comparison of Childhood and Adult Type I Diabetes MellitusNew England Journal of Medicine, 1989
- CLINICAL AND PATHOGENIC SIGNIFICANCE OF PANCREATIC-ISLET-CELL ANTIBODIES IN DIABETICS TREATED WITH ORAL HYPOGLYCÆMIC AGENTSThe Lancet, 1977
- ANTIBODIES TO PANCREATIC ISLET CELLS IN INSULIN-DEPENDENT DIABETICS WITH COEXISTENT AUTOIMMUNE DISEASEThe Lancet, 1974
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974